Endometrial polyps (EPs) are benign overgrowths of the endometrium, with the potential to cause severe complications, ranging from discomfort to inflammation and infertility. Dysfunction of endometrial fibroblasts may be a critical component leading to the development of polyps. Although surgical intervention is the common remedy for severe cases, it comes with drawbacks, including infection, bleeding, and risk of damage to the cervix and adjacent tissues. Adipose-derived mesenchymal stromal cells (ASCs) are at the focus of modern medicine, as key modulators of tissue homeostasis, inflammation, and tissue repair, rendering them prime candidate agents for tissue regeneration and cell-based therapies. In this study, EPs were isolated from patients admitted to the OB/GYN department at the Galilee Medical Center and extracted fibroblasts (endometrial polyp fibroblasts, EPFs) were isolated and characterized. ASCs were isolated from healthy patients. The effect of EPF- and ASC-conditioned media (CM) on polyp-derived fibroblasts was evaluated, in both 2D and 3D assays, as well as on the expression of matrix-related gene expression. Herein, EPFs exposed to ASC-CM exhibited reduced migration, invasion, contraction of hydrogels, and extracellular matrix deposition, compared with those exposed to EPF-CM. Altogether, this study suggests that ASCs may have a modulating effect on fibroblasts involved in forming EPs and may serve as the basis for conservative treatment strategies aimed at treating severe cases of EPs.
Get full access to this article
View all access options for this article.
References
1.
ÜnalB, DoğanS, FŞ Karaveli, T Şimşek, ErdoğanG and CandanerI. (2014). Giant endometrial polyp in a postmenopausal woman without hormone/drug use and vaginal bleeding. Case Rep Obstet Gynecol, 2014:1–4.
2.
YangJH, Der ChenC, ChenSU, YangYS and ChenMJ. (2015). Factors influencing the recurrence potential of benign endometrial polyps after hysteroscopic polypectomy. PLoS One, 10:e0144857.
3.
NijkangNP, AndersonL, MarkhamR and ManconiF. (2019). Endometrial polyps: pathogenesis, sequelae and treatment. SAGE Open Med, 7:205031211984824.
4.
MoonSH, LeeSE, JungIK, JeongJE, ParkWY, YiWH, SuhDS, YoonMS and KimKH. (2011). A giant endometrial polyp with tamoxifen therapy in postmenopausal woman. Korean J Obstet Gynecol, 54:836.
5.
Valle RF. (1983). Hysteroscopy for gynecologic diagnosis. Clin Obstet Gynecol, 26:253–276.
6.
ShokeirTA, ShalanHM and El-ShafeiMM. (2004). Significance of endometrial polyps detected hysteroscopically in eumenorrheic infertile women. J Obstet Gynaecol Res, 30:84–89.
7.
SalimS, WonH, Nesbitt-HawesE, CampbellN and AbbottJ. (2011). Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol, 18:569–581.
8.
VarastehNN, NeuwirthRS, LevinB and KeltzMD. (1999). Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol, 94:168–171.
9.
ChanSSC, TamWH, YeoW, YuMMY, NgDPS, WongAWY, KwanWH and YuenPM. (2007). A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. BJOG Int J Obstet Gynaecol, 114:1510–1515.
10.
LiF, WeiS, YangS, LiuZ and NanF. (2018). Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps. Pakistan J Med Sci, 34:1267–1271.
11.
LaganàAS, PalmaraV, GraneseR, CianciminoL, ChiofaloB and TrioloO. (2014). Desogestrel versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. Gynecol Endocrinol, 30:794–797.
12.
HessAP, NayakNR and GiudiceLC. (2006). Oviduct and endometrium: cyclic changes in the primate oviduct and endometrium. Knobil Neill's Physiol Reprod, 1:337–381.
13.
BarraganF, IrwinJC, BalayanS, EriksonDW, ChenJC, HoushdaranS, PiltonenTT, SpitzerTLB, GeorgeA, et al. (2016). Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis. Biol Reprod, 94:118.
14.
DunnCL, KellyRW and CritchleyHOD. (2003). Decidualization of the human endometrial stromal cell: an enigmatic transformation. Reprod Biomed Online, 7:151–161.
15.
SterodimasA, De FariaJ, NicarettaB and PitanguyI. (2010). Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthetic Surg, 63:1886–1892.
16.
ZukPA, ZhuM, MizunoH, HuangJ, FutrellJW, KatzAJ, BenhaimP, LorenzHP and HedrickMH. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 7:211–228.
17.
JacksonWM, NestiLJ and TuanRS. (2012). Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther, 3:20.
18.
ManningCN, MartelC, Sakiyama-ElbertSE, SilvaMJ, ShahS, GelbermanRH and ThomopoulosS. (2015). Adipose-derived mesenchymal stromal cells modulate tendon fibroblast responses to macrophage-induced inflammation in vitro. Stem Cell Res Ther, 6:74.
19.
KlemmtPAB, CarverJG, KennedySH, KoninckxPR and MardonHJ. (2006). Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril, 85:564–572.
20.
Al-SabbaghM, LamEWF and BrosensJJ. (2012). Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol, 358:208–215.
21.
HuhtinenK, Saloniemi-HeinonenT, Keski-RahkonenP, DesaiR, LaajalaD, StahleM, HäkkinenMR, AwosanyaM, SuvitieP, et al. (2014). Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions. J Clin Endocrinol Metab, 99:E2188–E2197.
22.
PiltonenTT, ChenJC, KhatunM, KangasniemiM, LiakkaA, SpitzerT, TranN, HuddlestonH, IrwinJC and GiudiceLC. (2015). Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro. Hum Reprod, 30:1203–1215.
23.
YugeA, NasuK, MatsumotoH, NishidaM and NaraharaH. (2007). Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis- associated fibrosis. Hum Reprod, 22:938–944.
GargettCE, NguyenHPT and YeL. (2012). Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord, 13:235–251.
26.
TrounsonA and McDonaldC. (2015). Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell, 17:11–22.
27.
GiordanoA, GalderisiU and MarinoIR. (2007). From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol, 211:27–35.
28.
ShresthaC, ZhaoL, ChenK, HeH and MoZ. (2013). Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media. Int J Endocrinol 2013:Article ID. 592454.
29.
HuCH, TsengYW, ChiouCY, LanKC, ChouCH, TaiCS, Da HuangH, HuCW, LiaoKH, et al. (2019). Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model. Stem Cell Res Ther, 10:275.
30.
SaheliM, BayatM, GanjiR, HendudariF, KheirjouR, PakzadM, NajarB and PiryaeiA. (2020). Human mesenchymal stem cells-conditioned medium improves diabetic wound healing mainly through modulating fibroblast behaviors. Arch Dermatol Res, 312:325–336.
31.
ShabbirA, ZisaD, LinH, MastriM, RoloffG, SuzukiG and LeeT. (2010). Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. Am J Physiol Hear Circ Physiol, 299:H1428–H1438.
32.
ShabbirA, CoxA, Rodriguez-MenocalL, SalgadoM and Van BadiavasE. (2015). Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev, 24:1635–1647.
33.
AshcroftKJ, SyedF and BayatA. (2013). Site-Specific Keloid Fibroblasts Alter the Behaviour of Normal Skin and Normal Scar Fibroblasts through Paracrine Signalling. PLoS One, 8:e75600.
34.
HanasonoMM, KitaM, MikulecAA, LonerganD and KochRJ. (2003). Autocrine growth factor production by fetal, keloid, and normal dermal fibroblasts. Arch Facial Plast Surg, 5:26–30.
WalterMNM, WrightKT, FullerHR, MacNeilS and JohnsonWEB. (2010). Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res, 316:1271–1281.
37.
ShingyochiY, OrbayH and MizunoH. (2015). Adipose-derived stem cells for wound repair and regeneration. Expert Opin Biol Ther, 15:1285–1292.
38.
AghajanovaL, HorcajadasJA, WeeksJL, EstebanFJ, NezhatCN, ContiM and GiudiceLC. (2010). The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology, 151:1341–1355.
39.
BurneyRO, TalbiS, HamiltonAE, KimCV, NyegaardM, NezhatCR, LesseyBA and GiudiceLC. (2007). Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology, 148:3814–3826.
40.
CheongML, LaiTH and Bin WuW. (2019). Connective tissue growth factor mediates transforming growth factor β-induced collagen expression in human endometrial stromal cells. PLoS One, 14:e0210765.
41.
ShinJM, ParkJH, ParkIH and LeeHM. (2015). Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy, 29:408–413.
42.
ShinJM, ParkJH, KangB, LeeSA, ParkIH and LeeHM. (2016). Effect of doxycycline on transforming growth factor-beta-1'induced matrix metalloproteinase 2 expression, migration, and collagen contraction in nasal polyp'derived fibroblasts. Am J Rhinol Allergy, 30:385–390.
43.
López-NouoaJM and NietoMA. (2009). Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med, 1:303–314.
44.
YanC, GrimmWA, GarnerWL, QinL, TravisT, TanN and HanYP. (2010). Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-α through bone morphogenic protein-2. Am J Pathol, 176:2247–2258.
45.
HinzB. (2009). Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep, 11:120–126.
46.
SpiekmanM, PrzybytE, PlantingaJA, GibbsS, Van Der LeiB and HarmsenMC. (2014). Adipose tissue-derived stromal cells inhibit TGF-β1-induced differentiation of human dermal fibroblasts and keloid scar-derived fibroblasts in a paracrine fashion. Plast Reconstr Surg, 134:699–712.
47.
O'KaneS and FergusonMWJ. (1997). Transforming growth factor βs and wound healing. Int J Biochem Cell Biol, 29:63–78.
48.
EldredJA, HodgkinsonLM, DawesLJ, ReddanJR, EdwardsDR and WormstoneIM. (2012). MMP2 activity is critical for TGFβ2-induced matrix contraction-implications for fibrosis. Invest Ophthalmol Vis Sci, 53:4085–4098.
49.
WebbAH, GaoBT, GoldsmithZK, IrvineAS, SalehN, LeeRP, LendermonJB, BheemreddyR, ZhangQ, et al. (2017). Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. BMC Cancer, 17:434.
50.
LiGC, YeQH, XueYH, SunHJ, ZhouHJ, RenN, JiaHL, ShiJ, WuJC, et al. (2010). Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci, 101:2546–2553.
51.
LozitoTP and TuanRS. (2011). Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol, 226:385–396.
52.
BasalovaN, SagaradzeG, ArbatskiyM, EvtushenkoE, KulebyakinK, GrigorievaO, AkopyanZ, KalininaN and EfimenkoA. (2020). Secretome of mesenchymal stromal cells prevents myofibroblasts differentiation by transferring fibrosis-associated microRNAs within extracellular vesicles. Cells, 9:1272.
53.
OhnishiS, SumiyoshiH, KitamuraS and NagayaN. (2007). Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett, 581:3961–3966.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
